Mereo BioPharma Group Plc (MREO)
0.41
+0.01
(+3.14%)
USD |
NASDAQ |
Mar 03, 16:00
0.3817
-0.03
(-6.90%)
After-Hours: 07:57
Mereo BioPharma Group Research and Development Expense (Annual) : 20.94M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Biodexa Pharmaceuticals Plc | 6.679M |
| NuCana Plc | 23.02M |
| Autolus Therapeutics Plc | 118.79M |
| Bicycle Therapeutics Plc | 216.26M |
| AstraZeneca PLC | 13.84B |